Everlab
PrivateLast Round
Series A
Jun 16, 2026
Est. Valuation
$345.35M
Total Funding Raised
$57.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Everlab operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Series A round in June 2026.
Everlab is a healthtech company that provides a preventative health platform designed to detect, prevent, and reverse disease risks through advanced diagnostics and personalized care plans.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Precision Medicine, Medical Imaging, Healthcare Analytics, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Everlab Comparables
Compare Everlab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealthScreen | 82% | |
| Lifeforce | 81% | |
| Superpower | 80% |
For institutional investors. Book with your work email.
Everlab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 16, 2026 | ||||
| Seed | Jul 22, 2025 | ||||
| Pre Seed | Dec 6, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Everlab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AirTree | Series A |
| AfterWork Ventures | Pre Seed, Seed |
| Plural | Series A |
| Plural | Series A |
| b2venture | Series A, Pre Seed |
| Left Lane Capital | Series A, Seed |
| TEN13 | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 78% MoM, reaching 308.6K.
- Aug 10, 2026
Job posting indicates expansion into the UK market.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 31, 2026
Everlab launches Everlab Concierge, available now to all members in the app, on Aug 31st '26.
For institutional investors. Book with your work email.
Everlab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Everlab's valuation, stock price, and market status.
Is Everlab a public or private company?
Everlab is a private company.
What is the current stock price of Everlab?
Everlab is a private company, so its shares have no public market price. Caplight tracks Everlab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Everlab worth (valuation)?
Everlab's valuation is estimated at $345.4M based on funding round data.
Can I buy Everlab stock?
Everlab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Everlab's last funding round?
Everlab's most recent funding round was Series A on June 16, 2026.
Who are the main investors in Everlab?
Key investors in Everlab include AirTree, b2venture, Left Lane Capital.
Will Everlab IPO soon?
No public IPO plans have been announced for Everlab.
How can I track Everlab secondary market activity?
Caplight tracks bids, offers, and trades in Everlab's shares on secondary markets.